Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
IPO Date: July 11, 2008
Sector: Healthcare
Industry: Biotech
Market Cap: $10.34B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.70 | 1.93%
Avg Daily Range (30 D): $3.09 | 1.88%
Avg Daily Range (90 D): $3.42 | 2.22%
Institutional Daily Volume
Avg Daily Volume: .14M
Avg Daily Volume (30 D): .37M
Avg Daily Volume (90 D): .43M
Trade Size
Avg Trade Size (Sh.): 69
Avg Trade Size (Sh.) (30 D): 45
Avg Trade Size (Sh.) (90 D): 48
Institutional Trades
Total Inst.Trades: 3,585
Avg Inst. Trade: $3.4M
Avg Inst. Trade (30 D): $4.98M
Avg Inst. Trade (90 D): $4.36M
Avg Inst. Trade Volume: .03M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.93M
Avg Closing Trade (30 D): $3.62M
Avg Closing Trade (90 D): $3.61M
Avg Closing Volume: 24.05K
   
News
Feb 20, 2025 @ 2:39 PM
Why Is BioMarin Stock Trading Higher On Thursday?
Source: Vandana Singh
Nov 4, 2024 @ 6:34 PM
Wegovy Manufacturer Inks Multi-Million Deal For Mo...
Source: Vandana Singh
Sep 25, 2024 @ 7:50 PM
BioMarin Stands Firm on 2027 Revenue Target Amid A...
Source: Vandana Singh
Sep 22, 2024 @ 9:34 PM
Bausch & Lomb And Edgewise Therapeutics Are Among ...
Source: Lekha Gupta
Sep 20, 2024 @ 12:16 AM
Ascendis Pharma A/S Announces Pricing of Public Of...
Source: N/A